Pharmaceutical Patent Pools Seen As A Life And Death Matter In Kenya 30/11/2009 by Nicholas Wadhams for Intellectual Property Watch Leave a Comment NAIROBI – At the headquarters of UNITAID and other groups seeking to boost access to HIV/AIDS medicine, the notion of a patent pool where drug companies would combine their intellectual property is seen as an important way to drive down drug costs. In the Kenyan capital Nairobi, home of AIDS activist Nelson Otwoma, the patent pool is a matter of life and death.
Kenyan AIDS Patients Seek To Overturn Anti-Counterfeiting Law As Unconstitutional 07/07/2009 by Nicholas Wadhams for Intellectual Property Watch 3 Comments NAIROBI – Three HIV/AIDS patients in Kenya announced Tuesday they will petition the country’s Constitutional Court to declare a new anti-counterfeiting act illegal because it could deny them access to generic medicines. The move, which has the support of public health groups across the country, seeks to have the 2008 Anti-Counterfeiting Act made unconstitutional on the grounds that it could rob them of their right to life.
Report: Drug Companies Violating WHO Ethics On Advertising In East Africa 02/07/2009 by Nicholas Wadhams for Intellectual Property Watch Leave a Comment NAIROBI – Drug companies routinely violate World Health Organization ethical guidelines when advertising and promoting their products in East Africa, according to a new study released Thursday.
Kenya Pressured To Implement Anti-Counterfeit Law Despite Access Fears 02/07/2009 by Nicholas Wadhams for Intellectual Property Watch 4 Comments NAIROBI – An influential manufacturers’ lobbying group in Kenya is pushing the government to start enforcing an anti-counterfeiting law within weeks, despite fears from public health advocates that the new rules will impede access to generic drugs and set an unwanted precedent in East Africa.
Kenya Conference: Financial Incentives Needed For Tailored Neglected Disease Research 16/03/2009 by Nicholas Wadhams for Intellectual Property Watch Leave a Comment NAIROBI – Governments in Kenya and other developing nations must be willing to provide financial incentives if they expect companies to carry out research and development of drugs specifically tailored to those countries’ needs, a conference in Nairobi was told last week.
Rapid Rise In African Anti-Counterfeiting Efforts Led By Developed Nations 09/12/2008 by Nicholas Wadhams for Intellectual Property Watch Leave a Comment By Nick Wadhams for Intellectual Property Watch NAIROBI, KENYA – Amid fears that huge quantities of counterfeit medicines and pesticides are pouring into Africa, the international law enforcement agency INTERPOL is leading the way to invest more effort and money to bring authorities up to speed on the threat faced by those who depend on […]
